[How must we manage epileptic encephalopathies in infants? Conclusions]
Related Experiment Video
Updated: Mar 2, 2026

Application of an Amplitude-integrated EEG Monitor Cerebral Function Monitor to Neonates
Published on: September 6, 2017
1Fundacion Jimenez Diaz, Madrid, Espana.
Insights
Epileptic encephalopathies cause significant cognitive and behavioral issues. A new diagnostic algorithm aids early treatment by integrating EEG, neuroimaging, and genetic/metabolic screening for infants.
Area of Science:
- Neurology
- Pediatrics
- Genetics
Background:
- Epileptic encephalopathies are severe neurological disorders where epileptic activity exacerbates cognitive and behavioral impairments.
- Early etiological diagnosis is crucial for timely and effective treatment interventions.
Purpose of the Study:
- To present a diagnostic algorithm for identifying the cause of epileptic encephalopathy in infants.
- To guide clinicians in the early management of these complex pediatric neurological conditions.
Main Methods:
- The proposed algorithm integrates electroencephalographic (EEG) studies, neuroimaging, and comprehensive screening for metabolic and genetic disorders.
- It emphasizes a coordinated approach to diagnostic investigations.
Main Results:
- The algorithm facilitates a systematic etiological diagnosis for early-onset epileptic encephalopathy.
- This structured approach aims to improve treatment outcomes by identifying underlying causes.
Conclusions:
- A coordinated diagnostic algorithm is essential for the early and accurate diagnosis of infantile epileptic encephalopathy.
- Implementing this algorithm can lead to prompt and targeted therapeutic strategies, improving patient prognosis.
Abstract:
Epileptic encephalopathies are defined as epileptic syndromes in which the epileptic activity per se (in the form of frequent seizures or the presence of interictal epileptiform activity) contributes to a cognitive and behavioural disorder that is more important than could be expected from the causation of the disorder. Their aetiological diagnosis is fundamental to allow an early treatment to be established. We propose a diagnostic algorithm for patients with epileptic encephalopathy with onset during the first year of life, which includes management coordinated with electroencephalographic studies, neuroimaging, and screening for metabolic and genetic disorders.
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Glutamate Antagonists
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...

